Abstract

PreScription: Potpourri of Opinions…From Many

Author(s): Allen Loyd V

Issue: Jul/Aug 2015 - Volume 19, Number 4

Page(s): 266

Download in electronic PDF format for $75
  • PreScription: Potpourri of Opinions…From Many Page 1

Abstract

Related Keywords

  • third party pay
  • pharmacy benefit managers
  • PBM
  • science training in pharmacy education
  • pharmaceutical sciences
  • math skills
  • U.S. Food and Drug Administration
  • FDA
  • government authority
  • state boards of pharmacy
  • pharmacist professionalism

Related Categories

  • LEGAL
  • PHARMACY EDUCATION
  • PROFESSIONAL ISSUES

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2015
Pg. 266
PreScription: Potpourri of Opinions…From Many
Author(s): Allen Loyd V
Sep/Oct 2017
Pg. 356
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Author(s): Allen Loyd V Jr
Jul/Aug 2016
Pg. 351
View Sample
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Author(s): Allen Loyd V Jr
Mar/Apr 2017
Pg. 95-102
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Author(s): Yoch Doug
Mar/Apr 2010
Pg. 134
Owning an In-Network Pharmacy and a Second Out-of-Network Pharmacy that Performs Compounding: Suggestions on How to Avoid Being Terminated from the Pharmacy Benefits Manager Network
Author(s): Levitt Jonathan E, Mizeski Todd
Jan/Feb 2017
Pg. 4
PreScription: Compounding Pharmacy Issues for 2017
Author(s): Allen Loyd V Jr
Jan/Feb 2019
Pg. 32-33
U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line
Author(s): Snow Stephen T, Stannard Robert W, Bellis Jennifer, Moss Carrie A
Jul/Aug 2020
Pg. 296-297
Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed
Author(s): Brunner Scott
Jul/Aug 2015
Pg. 303-305
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Author(s): Miller David G
May/Jun 2014
Pg. 208
The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter
Author(s): Miller David G
Nov/Dec 2015
Pg. 487-488
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Author(s): Allen Loyd V Jr
Jan/Feb 2018
Pg. 7-16
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies
Author(s): Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
Mar/Apr 2007
Pg. 92
PreScription: Putting the Science Back into Pharmacy
Author(s): Allen Loyd V Jr
May/Jun 2022
Pg. 182-186
Art of Pharmacy v. State
Author(s): Standridge Rob
Jan/Feb 2023
Pg. 22-23
The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone
Author(s): Brunner Scott
Jan/Feb 2015
Pg. 30-37
Agar Transfer Devices for Environmental Sampling in the Compounding Pharmacy: Science and Compliance
Author(s): Grilli Anthony, Sutton Scott
Jan/Feb 2014
Pg. 87
PostScription: Pharmacy Benefit Managers and Compounding Pharmacists: Billing for Services
Author(s): Lees Deril J
Sep/Oct 2015
Pg. 389-390
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1
Author(s): Allen Loyd V Jr
Jul/Aug 2007
Pg. 326-327
Standard Operating Procedure: U.S. Food and Drug Administration Inspection--Releasing a Sample to the U.S. Food and Drug Administration
Author(s): Kupiec Tom, Kemp Jesse
May/Jun 2023
Pg. 208-210
Show Me the Science: A Perspective
Author(s): Grzib Anthony